THE cost of clinical trials looking at gaps in medical evidence is outweighed almost sixfold by the savings that flow from the health improvements experienced by patients, as well as the direct savings to the health system and the wider economy.
A new report launched yesterday by the Australian Commission on Safety and Quality in Health Care and the Australian Clinical Trials Alliance analysed 25 local trials initiated by clinicians, finding if the results were implemented in just two thirds of the relevant patient groups for one year, $1.4b would be saved through improved patient health outcomes - plus a further $580m in health savings.
See safetyandquality.gov.au.
The above article was sent to subscribers in Pharmacy Daily's issue from 02 Aug 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 02 Aug 17
